My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.060 +0.010 (+0.95%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 02, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

July 02, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

July 01, 2025

From AVACTA GROUP PLC

Via GlobeNewswire

Top 3 Health Care Stocks That Could Blast Off This Month ↗

January 06, 2025

Via Benzinga

The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals ↗

November 18, 2024

Via Benzinga

A Preview Of Inovio Pharmaceuticals's Earnings ↗

November 13, 2024

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

8 Health Care Stocks Whale Activity In Today's Session ↗

May 01, 2025

Via Benzinga

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript ↗

March 18, 2025

INO earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For March 18, 2025 ↗

March 18, 2025

Via Benzinga

What's Going On With Inovio Pharmaceuticals (INO) Stock? ↗

January 08, 2025

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday's session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.

Via Benzinga

The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts ↗

October 04, 2024

Via Benzinga

Why Inovio Pharmaceuticals (INO) Stock Is Skyrocketing ↗

January 07, 2025

Inovio Pharmaceuticals shares are trading higher by 20.7% Tuesday afternoon. Vaccine stocks are rising amid growing concerns about respiratory illnesses.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 13, 2024

Via Benzinga

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet ↗

December 13, 2024

Via Benzinga

Crude Oil Gains Over 1%; RH Shares Jump On Strong Forecast ↗

December 13, 2024

Via Benzinga

US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings ↗

December 13, 2024

Via Benzinga

Why Inovio Pharmaceuticals (INO) Stock Is Down 40% ↗

December 13, 2024

Inovio Pharmaceuticals shares are trading lower by 38% during Friday's session. The company priced a public offering of 10 million shares of common stock and accompanying warrants.

Via Benzinga

US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focus ↗

December 13, 2024

U.S. stock futures advanced on Friday in premarket after declining on Thursday. The futures of all four major indices were trading higher.

Via Benzinga

Topics Economy

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

December 13, 2024

Via Benzinga

RH, Broadcom And 3 Stocks To Watch Heading Into Friday ↗

December 13, 2024

Via Benzinga

European And US Vaccine Stocks Are Under Pressure - Here's WHy ↗

November 15, 2024

Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.

Via Benzinga

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript ↗

November 14, 2024

INO earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript ↗

August 09, 2024

INO earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗

August 08, 2024

INO stock results show that Inovio Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Better Buy: Inovio Pharmaceuticals vs. Novavax ↗

May 22, 2024

Both biotechs have been struggling for a while, but there might be some hope for them.

Via The Motley Fool

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 20, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.